BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+6.86%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$4.54B
AUM Growth
+$4.54B
(+1.7%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
49.79%
Holding
155
New
7
Increased
39
Reduced
61
Closed
13
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$39.2M |
| 2 |
Immunocore
IMCR
|
$38.3M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$36.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
$20M |
| 5 |
Edgewise Therapeutics
EWTX
|
$17.7M |
Top Sells
| 1 |
Incyte
INCY
|
$35.5M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$29.9M |
| 3 |
Intuitive Surgical
ISRG
|
$25.6M |
| 4 |
Boston Scientific
BSX
|
$20M |
| 5 |
Cencora
COR
|
$19M |
Sector Composition
| 1 | Healthcare | 99.88% |
| 2 | Technology | 0.01% |
| 3 | Consumer Discretionary | 0.01% |
| 4 | Communication Services | 0.01% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Transmedics
TMDX
$3.92B
| $17.5M | 0.39% |
130,517
-43,193
| -25% | -$5.79M |
|
52
Encompass Health
EHC
$12.3B
| $16.2M | 0.36% |
131,741
-41,137
| -24% | -$5.04M |
|
53
Hologic
HOLX
$14.9B
| $16.2M | 0.36% |
247,886
| – | – |
|
54
Exact Sciences
EXAS
$9.09B
| $15.1M | 0.33% |
284,201
-294,873
| -51% | -$15.7M |
|
55
Masimo
MASI
$7.59B
| $15.1M | 0.33% |
89,673
+19,865
| +28% | +$3.34M |
|
56
CareDx
CDNA
$727M
| $14.7M | 0.32% |
752,371
-136,632
| -15% | -$2.67M |
|
57
Privia Health
PRVA
$2.83B
| $14.5M | 0.32% |
630,697
-66,611
| -10% | -$1.53M |
|
58
Regeneron Pharmaceuticals
REGN
$61.5B
| $14M | 0.31% |
26,744
-1,779
| -6% | -$934K |
|
59
Annexon
ANNX
$226M
| $12.4M | 0.27% |
5,157,290
| – | – |
|
60
Humana
HUM
$36.5B
| $12M | 0.26% |
49,124
+20,826
| +74% | +$5.09M |
|
61
MacroGenics
MGNX
$110M
| $12M | 0.26% |
9,919,992
-9,971
| -0.1% | -$12.1K |
|
62
Johnson & Johnson
JNJ
$427B
| $10.4M | 0.23% |
68,211
+1,202
| +2% | +$184K |
|
63
SI-BONE Inc
SIBN
$719M
| $10.2M | 0.22% |
540,112
-332,879
| -38% | -$6.26M |
|
64
Inspire Medical Systems
INSP
$2.77B
| $9.82M | 0.22% |
75,660
-23,367
| -24% | -$3.03M |
|
65
Labcorp
LH
$23.1B
| $9.63M | 0.21% |
36,692
+8,551
| +30% | +$2.24M |
|
66
Phreesia
PHR
$1.88B
| $9.45M | 0.21% |
332,016
-44,147
| -12% | -$1.26M |
|
|
ONC
67
BeOne Medicines Ltd. American Depositary Shares
ONC
$33.7B
| $9.37M | 0.21% |
38,698
+3,369
| +10% | +$816K |
|
68
Quest Diagnostics
DGX
$20.3B
| $8.72M | 0.19% |
+48,567
| New | +$8.72M |
|
69
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.32M | 0.18% |
151,445
-216,928
| -59% | -$11.9M |
|
70
Insmed
INSM
$28.8B
| $8.19M | 0.18% |
81,397
-69,153
| -46% | -$6.96M |
|
71
Centene
CNC
$14.5B
| $7.56M | 0.17% |
139,310
+53,092
| +62% | +$2.88M |
|
72
Structure Therapeutics
GPCR
$1.16B
| $7.23M | 0.16% |
348,527
+126,812
| +57% | +$2.63M |
|
73
Teva Pharmaceuticals
TEVA
$21.5B
| $7.06M | 0.16% |
421,501
+392,571
| +1,357% | +$6.58M |
|
74
Black Diamond Therapeutics
BDTX
$159M
| $6.78M | 0.15% |
2,733,547
| – | – |
|
75
Amgen
AMGN
$155B
| $6.73M | 0.15% |
24,108
-56,827
| -70% | -$15.9M |
|